OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
RWB.CD59

Red White & Bloom Brands Inc

Healthcare Facilities & ServicesVerified

Red White & Bloom Brands Inc exhibits a highly leveraged capital structure, with a debt-to-equity ratio of -1.75, indicating that liabilities significantly exceed equity. The company holds only $4.57 million in cash and equivalents, while long-term debt stands at $420.69 million, creating a liquidity risk as operating cash flow is negative at -$9.57 million. The negative net cash position further exacerbates this risk, as the company's cash reserves are insufficient to cover its debt obligations. Profitability metrics show the company is not generating returns that meet industry norms. With a negative total equity of -$240.97 million and a revenue of $64.83 million, the company is underperforming in terms of return on invested capital and operating margins. These figures suggest that the company is not effectively converting its capital into profit, which is a concern for investors. The company's revenue is distributed across four segments: Distribution, Licensing, Retail, and Corporate and Other. The Distribution segment is the primary source of operations, involving cultivation, manufacturing, and distribution of cannabis products. The Licensing segment generates revenue through intellectual property and brand licensing, while the Retail segment sells both Company and third-party products. However, the financial data does not provide a breakdown of revenue by segment, making it difficult to assess the performance of each business line. The company's growth trajectory is uncertain, as the financial data does not provide forward-looking revenue projections. The current fiscal year's revenue of $64.83 million is a key figure, but without comparative data from previous years or analyst estimates for the next fiscal year, it is challenging to determine the company's growth rate. The negative operating cash flow and high debt levels suggest that the company may face challenges in sustaining growth without additional financing. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position is a key flag, suggesting that it may need to raise additional capital to meet its obligations. The dilution risk is low, implying that the company is not expected to issue a significant number of new shares in the near term. However, the company's high debt levels and negative equity could lead to financial distress if it is unable to generate positive cash flow. Recent events and filings have not been disclosed in the provided data, so there is no information on recent corporate actions, earnings calls, or regulatory developments that could impact the company's operations or financial position. The absence of such information limits the ability to assess the company's recent performance and strategic direction.

30-day price · RWB.CD+0.03 (+250.0%)
Low$0.01High$0.04Close$0.04As of17 May, 00:00 UTC
Profile
CompanyRed White & Bloom Brands Inc
TickerRWB.CD
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Red White & Bloom Brands Inc operates as a multi-state cannabis operator in the United States and Canada, generating revenue through cultivation, manufacturing, distribution, retail sales, and brand licensing of cannabis and non-cannabis products.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Services & Equipment business sector and Healthcare Facilities & Services industry, with a confidence level of 0.92.

Red White & Bloom Brands Inc exhibits a highly leveraged capital structure, with a debt-to-equity ratio of -1.75, indicating that liabilities significantly exceed equity. The company holds only $4.57 million in cash and equivalents, while long-term debt stands at $420.69 million, creating a liquidity risk as operating cash flow is negative at -$9.57 million. The negative net cash position further exacerbates this risk, as the company's cash reserves are insufficient to cover its debt obligations. Profitability metrics show the company is not generating returns that meet industry norms. With a negative total equity of -$240.97 million and a revenue of $64.83 million, the company is underperforming in terms of return on invested capital and operating margins. These figures suggest that the company is not effectively converting its capital into profit, which is a concern for investors. The company's revenue is distributed across four segments: Distribution, Licensing, Retail, and Corporate and Other. The Distribution segment is the primary source of operations, involving cultivation, manufacturing, and distribution of cannabis products. The Licensing segment generates revenue through intellectual property and brand licensing, while the Retail segment sells both Company and third-party products. However, the financial data does not provide a breakdown of revenue by segment, making it difficult to assess the performance of each business line. The company's growth trajectory is uncertain, as the financial data does not provide forward-looking revenue projections. The current fiscal year's revenue of $64.83 million is a key figure, but without comparative data from previous years or analyst estimates for the next fiscal year, it is challenging to determine the company's growth rate. The negative operating cash flow and high debt levels suggest that the company may face challenges in sustaining growth without additional financing. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position is a key flag, suggesting that it may need to raise additional capital to meet its obligations. The dilution risk is low, implying that the company is not expected to issue a significant number of new shares in the near term. However, the company's high debt levels and negative equity could lead to financial distress if it is unable to generate positive cash flow. Recent events and filings have not been disclosed in the provided data, so there is no information on recent corporate actions, earnings calls, or regulatory developments that could impact the company's operations or financial position. The absence of such information limits the ability to assess the company's recent performance and strategic direction.
Key takeaways
  • Red White & Bloom Brands Inc has a highly leveraged capital structure with a debt-to-equity ratio of -1.75, indicating significant financial risk.
  • The company's negative operating cash flow and high debt levels suggest a liquidity risk, as it may need to raise additional capital to meet obligations.
  • The company's profitability metrics are weak, with a negative total equity of -$240.97 million and a revenue of $64.83 million.
  • The company's growth trajectory is uncertain, as there is no comparative data from previous years or analyst estimates for the next fiscal year.
  • The risk assessment indicates a medium liquidity risk and a low dilution risk, but the company's financial position could deteriorate if it is unable to generate positive cash flow.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCAD
Revenue$64.8M
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow-$9.6M
CapEx-$5.4M
Free cash flow
Total assets
Total liabilities$454.1M
Total equity-$241.0M
Cash & equivalents$4.6M
Long-term debt$420.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash-$416.1M
Current ratio
Debt/Equity-1.8
ROA
ROE
Cash conversion
CapEx/Revenue-8.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Pharmaceuticals · cohort 25 companies
MetricRWB.CDActivity
Op margin18.2% medp25 18.2% · p75 24.6%
Net margin14.7% medp25 11.7% · p75 28.1%
Gross margin19.7% medp25 19.7% · p75 39.8%
R&D / revenue24.3% medp25 6.6% · p75 24.3%
CapEx / revenue-8.3%4.9% medp25 4.2% · p75 6.3%bottom quartile
Debt / equity-175.0%71.3% medp25 19.0% · p75 91.7%bottom quartile
Observations
IR observations
Last actual EPS-0.05 CAD
Last actual revenue17,408,000 CAD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 02:44 UTC#62fa28c4
Source: analysis-pipeline (hybrid)Generated: 2026-05-05 02:45 UTCJob: 69248a67